Chairman and Chief Executive Officer · Actinium Pharmaceuticals, Inc. (ATNM)

Sandesh Seth

A named executive officer of Actinium Pharmaceuticals in every fiscal year CompBrief holds from FY2017 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2025

$1,187,320

Salary $762,320Stock awards $0Bonus $425,000

FY2024: $1,173,200

1st of 2 named executive officers at Actinium Pharmaceuticals by FY2025 total.

2 named officers on file for Actinium Pharmaceuticals, FY2025

Sandesh Seth’s pay file — $29

  • 9 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Actinium Pharmaceuticals’s whole pay program stands against its peers

  • Actinium Pharmaceuticals’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ATNM→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 16, 2026 (DEF 14A).

Free

Get Sandesh Seth’s full pay file as a PDF — free

More than this page: up to 10 years of Sandesh’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Sandesh Seth compensation by year

Actinium Pharmaceuticals Summary Compensation Table · all 9 fiscal years held
In US dollars, as Actinium Pharmaceuticals reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Salary$306,250$545,000$561,350$578,191$615,000$665,000$705,000$733,200$762,320
Bonus$0$280,000$300,000$315,000$430,000$480,000$500,000$440,000$425,000
Stock awards$0$0$0$0$0$0$0$0$0
Option awards$0$549,253$241,367$938,537$1,290,323$2,875,167$3,500,000$0$0
Non-equity incentive$0$0$0$0$0$0$0$0$0
Pension and deferred compensation$0$0$0$0$0$0$0$0$0
All other$0$0$0$0$0$0$0$0$0
Total$306,250$1,374,253$1,102,717$1,831,728$2,335,323$4,020,167$4,705,000$1,173,200$1,187,320

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Actinium Pharmaceuticals, Inc. DEF 14A filed October 16, 2026, accession 0001213900-26-110022, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Actinium Pharmaceuticals, Inc. filed document, accession 0001213900-26-110022. Every figure is read from that document and cited to the page and table it appears in. Filed October 16, 2026.

$306K
$1.4M
$1.1M
$1.8M
$2.3M
$4.0M
$4.7M
$1.2M
$1.2M
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
SalaryBonusOption awards

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU300,000$378,000—
Option748,119—$5.00
Option68,241—$6.07
Option347,494—$4.96

Per the Outstanding Equity Awards at Fiscal Year-End table in Actinium Pharmaceuticals, Inc.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Actinium Pharmaceuticals’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Sandesh Seth · this pageChairman and Chief Executive Officer$1,187,320
Steve O’LoughlinFormer Chief Financial Officer (through February 2026)$546,437

Board service

Actinium Pharmaceuticals board · FY2024–FY2025

How this board is paid

Company policy: Actinium Pharmaceuticals pays directors a $45,000 cash retainer. As stated in Actinium Pharmaceuticals's FY2025 proxy.

The full Actinium Pharmaceuticals compensation record

free company brief

This page is one person within Actinium Pharmaceuticals's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Actinium Pharmaceuticals's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Sandesh Seth's compensation dossier · One-time report. No refunds.